Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $55.13 USD
Change Today +0.45 / 0.82%
Volume 262.2K
As of 8:04 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Donald E. Morel Jr., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 58 board members in 3 different organizations across 4 different industries.

See Board Relationships
56$4,889,983
As of Fiscal Year 2014

Background*

Dr. Donald E. Morel Jr., Ph.D. served as the Chief Executive Officer of West Pharmaceutical Services, Inc. from April 2002 to April 24, 2015. Dr. Morel served as the President of West Pharmaceutical Services Inc. from April 2002 to June 2005, Chief Operating Officer from May 2001 to April 2002, Division President, Drug Delivery Systems from October 1999 to May 2001, Group President from April 1998 to October 1999 and Vice President, Scientific Services since November ...

Read Full Background

Corporate Headquarters*

530 Herman O. West Drive
Exton, Pennsylvania 19341

United States

Phone: 610-594-2900
Fax: --

Board Members Memberships*

Director
1995-N/A
Former Director
2002-Present
Chairman
2010-2012
Former Director, Member of Audit Committee and Member of Compensation Committee
2013-Present
Director and Member of Compensation Committee

Education*

BS
Lafayette College
MS
Cornell University
PhD
Cornell University

Other Affiliations*

Annual Compensation*

Salary$837,721
Total Annual Compensation$837,721

Stock Options*

Restricted Stock Awards$1,200,022
All Other Compensation$95,756
Exercisable Options844,568
Exercisable Options Value$27,753,243
Unexercisable Options462,638
Unexercisable Options Value$10,522,712
Total Value of Options$38,275,954
Total Number of Options1,307,206

Total Compensation*

Total Annual Cash Compensation$1,657,357
Total Short Term Compensation$837,721
Other Long Term Compensation$1,295,778
Total Calculated Compensation$4,889,983
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WST:US $55.13 USD +0.45

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jonathan W. Ayers Chairman, Chief Executive Officer and President
IDEXX Laboratories, Inc.
$800.0K
Walter M. Rosebrough Jr.Chief Executive Officer, President, Director and Member of Compliance Committee
Steris Corp.
$788.5K
Jeffrey T. Slovin Chief Executive Officer, President and Director
Sirona Dental Systems Inc.
$850.0K
Uwe Röhrhoff Chairman of the Management Board and Chief Executive Officer
Gerresheimer AG
€1.1M
Kevin J. McNamara Chief Executive Officer, President and Director
Chemed Corp.
$904.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WEST PHARMACEUTICAL SERVICES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.